CINECA IRIS Institutional Research Information System

RAGUSA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.790
EU - Europa 1.342
AS - Asia 709
AF - Africa 82
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.758
IT - Italia 688
CN - Cina 362
SE - Svezia 341
SG - Singapore 172
BG - Bulgaria 110
VN - Vietnam 79
DE - Germania 62
CI - Costa d'Avorio 39
GB - Regno Unito 34
CA - Canada 30
RU - Federazione Russa 27
TR - Turchia 24
IQ - Iraq 23
NG - Nigeria 20
SN - Senegal 20
HK - Hong Kong 18
IN - India 18
AT - Austria 12
PL - Polonia 11
NL - Olanda 10
FI - Finlandia 8
FR - Francia 8
IE - Irlanda 8
AU - Australia 5
CZ - Repubblica Ceca 5
BE - Belgio 4
CH - Svizzera 4
UA - Ucraina 4
IR - Iran 3
JP - Giappone 3
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
MX - Messico 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 4.936
Salva come PNG Salva come JPEG
Città #
Fairfield 400
Santa Clara 357
Ashburn 215
Woodbridge 205
Chandler 179
Seattle 169
Milan 166
Shanghai 164
Cambridge 149
Pisa 145
Houston 138
Wilmington 132
Serra 124
Sofia 110
Singapore 96
New York 76
Princeton 72
Boardman 70
Ann Arbor 58
Lawrence 46
Medford 42
Florence 40
Abidjan 39
Beijing 37
Dong Ket 27
Boulder 26
Redwood City 23
San Diego 23
Rome 22
Frankfurt am Main 21
Istanbul 21
Bremen 20
Dakar 20
Des Moines 19
Fuzhou 19
Ottawa 19
Hong Kong 18
Lagos 18
Sulaymaniyah 18
Ogden 16
Livorno 15
Nanjing 15
Carrara 13
Los Angeles 13
Dearborn 12
London 12
Washington 12
Norwalk 11
Vienna 10
Warsaw 9
Dublin 8
Guangzhou 8
Hyderabad 8
Quanzhou 8
Amsterdam 7
Changsha 7
Chengdu 7
Toronto 6
Wuhan 6
Massa 5
Tianjin 5
Xiamen 5
Brussels 4
Dallas 4
Fremont 4
Helsinki 4
Jiaxing 4
Kilburn 4
Lucca 4
Naples 4
Phoenix 4
San Francisco 4
Santa Croce sull'Arno 4
Serpukhov 4
Shenyang 4
St Petersburg 4
Zhengzhou 4
Agliana 3
Bern 3
Kent 3
Minneapolis 3
Nuremberg 3
Pomezia 3
Absecon 2
Alexandria 2
Basra 2
Bedford 2
Boston 2
Cascina 2
Castano Primo 2
Cavriglia 2
Gabbro 2
Gunzenhausen 2
Hebei 2
Hefei 2
Islington 2
Kunming 2
Lancaster 2
Lappeenranta 2
Melbourne 2
Totale 3.873
Salva come PNG Salva come JPEG
Nome #
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 153
Sunitinib in the treatment of thyroid cancer 139
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 133
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 132
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 126
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 126
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 117
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 116
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 112
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 112
Novel treatment options for anaplastic thyroid cancer 110
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 110
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 106
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 106
Novel therapies for thyroid autoimmune diseases: An update 106
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 105
Molecular testing in the diagnosis of differentiated thyroid carcinomas 104
Oral L-thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study 102
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 100
Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis 99
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 99
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy 97
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 96
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 96
New insight in endocrine-related adverse events associated to immune checkpoint blockade 95
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 94
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 94
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 94
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 93
Chemokines in hyperthyroidism 91
The protective effect of myo-inositol on human thyrocytes 89
Novel treatments for anaplastic thyroid carcinoma 87
Immune and inflammatory cells in thyroid cancer microenvironment 85
Th1 chemokines in autoimmune endocrine disorders 84
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 82
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 79
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 77
null 75
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 75
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 75
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 72
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 70
Thyroid autoimmune disorders and cancer 66
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 64
Endocrine disruptors and thyroid autoimmunity 60
Precision Medicine in Graves’ Disease and Ophthalmopathy 59
L-T4 Therapy in Enteric Malabsorptive Disorders 57
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 55
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 48
Chemokines in thyroid autoimmunity 45
Teprotumumab for the treatment of thyroid eye disease 45
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 45
Molecular features of aggressive thyroid cancer 42
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 42
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 37
Myoinositol in Autoimmune Thyroiditis 36
Thyroid Metastasis from Primary Breast Cancer 35
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 35
Thyroid Autoimmunity and SARS-CoV-2 Infection 31
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 27
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 24
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 20
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 18
Hypothyroidism and metabolic cardiovascular disease 17
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 14
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 13
Sarcoidosis and Th1 chemokines 10
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity 10
Sarcoidosis and the Th1 chemokine MIG 9
Autoimmune Thyroid Diseases and Epigenetics 9
Mesothelioma and interferon-γ-dependent chemokine IP-10 9
IP-10 in occupational asthma: review of the literature and case-control study 9
Dermatomyositis and MIG 9
MIG chemokine in systemic sclerosis. MIG in Systemic sclerosis 9
Th1 chemokines in ulcerative colitis 8
Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells 4
Totale 5.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020580 0 0 0 0 0 0 104 112 195 73 59 37
2020/2021492 38 54 51 12 23 24 18 53 34 61 28 96
2021/2022715 13 14 28 47 109 92 32 33 67 59 56 165
2022/2023770 118 106 67 37 68 92 34 46 122 5 62 13
2023/2024836 67 78 121 97 120 135 55 24 12 17 38 72
2024/20251.027 119 72 72 140 259 310 55 0 0 0 0 0
Totale 5.234